Clinical Trials Browser

Interventional × Has announcements × darolutamide × Clear all

NCT02799602 2025-12-04

ARASENS

Phase 3 Completed

1,306 enrolled 25 charts 5 FDA

Metastatic Hormone-sensitive Prostate Cancer

NCT02200614 2022-06-28

ARAMIS

Phase 3 Completed

1,509 enrolled 13 charts 2 FDA

Prostate Cancer Non-Metastatic